Cargando…
Comparing efficacy and safety of different doses of dexamethasone in the treatment of COVID-19: a three-arm randomized clinical trial
BACKGROUND AND OBJECTIVES: Corticosteroids are commonly used in the treatment of hospitalized patients with COVID-19. The goals of the present study were to compare the efficacy and safety of different doses of dexamethasone in the treatment of patients with a diagnosis of moderate to severe COVID-1...
Autores principales: | Toroghi, Negar, Abbasian, Ladan, Nourian, Anahid, Davoudi-Monfared, Effat, Khalili, Hossein, Hasannezhad, Malihe, Ghiasvand, Fereshteh, Jafari, Sirous, Emadi-Kouchak, Hamid, Yekaninejad, Mir Saeed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627167/ https://www.ncbi.nlm.nih.gov/pubmed/34837648 http://dx.doi.org/10.1007/s43440-021-00341-0 |
Ejemplares similares
-
Comparing outcomes of hospitalized patients with moderate and severe COVID-19 following treatment with hydroxychloroquine plus atazanavir/ritonavir
por: Rahmani, Hamid, et al.
Publicado: (2020) -
Comparing efficacy and safety of tocilizumab and methylprednisolone in the treatment of patients with severe COVID-19
por: Abbasian, Ladan, et al.
Publicado: (2022) -
A Randomized Clinical Trial of the Efficacy and Safety of Interferon β-1a in Treatment of Severe COVID-19
por: Davoudi-Monfared, Effat, et al.
Publicado: (2020) -
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial
por: Rahmani, Hamid, et al.
Publicado: (2020) -
Efficacy and safety of sofosbuvir/ledipasvir in treatment of patients with COVID-19; A randomized clinical trial
por: Nourian, Anahid, et al.
Publicado: (2020)